Clinical Trial Update: A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use [Phase 2]

View source ↗

Summary

Phase II trial update evaluating sofobuvir and GS-5816 for chronic hepatitis C in people with recent injection drug use; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• GS-5816 (GS-5816)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Kirby Institute | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED